{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-168460","form_type":"8-K","ticker":"IRON","cik":"0001816736","company_name":"Disc Medicine, Inc.","filed_at":"2023-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.805622+00:00","generated_at":"2026-06-13T23:07:34.513607+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Disc Medicine prices upsized $137.2M public offering of common stock and pre-funded warrants","bullets":["Priced 2,595,919 shares at $49.00 per share and 204,081 pre-funded warrants at $48.9999 each.","Gross proceeds ~$137.2M before discounts/expenses; net proceeds expected ~$128.2M (~$147.6M if option exercised).","Underwriters granted 30-day option to purchase up to 420,000 additional shares at offering price less discounts.","Proceeds to fund research, clinical development, working capital, and general corporate purposes.","Offering expected to close June 16, 2023; joint book-runners: Morgan Stanley, SVB Securities, Stifel, BMO Capital Markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-168460","json":"https://secwatch.observer/filing/0001193125-23-168460.json","markdown":"https://secwatch.observer/filing/0001193125-23-168460.md","text":"https://secwatch.observer/filing/0001193125-23-168460.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816736/000119312523168460/0001193125-23-168460-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816736/000119312523168460/d481795d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:07:34.513607+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"16ff0db2645d089fc24b813db75021b3c87b7e21","claim":"Disc Medicine, Inc. entered into Underwriting Agreement with Morgan Stanley & Co. LLC, SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated, BMO Capital Markets Corp. valued at $128.2 million net proceeds from public offering of common stock and pre-funded warrants (effective 2023-06-13).","evidence_excerpt":"On June 13, 2023, Disc Medicine, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC, SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated, and BMO Capital Markets Corp., as representatives of the several underwriters listed on Schedule I thereto (the “Underwriters”), related to a public offering (the “Offering”) of (i) 2,595,919 shares of common stock of the Company, par value $0.0001 per share (“Common Stock”) at a price to the public of $49.00 per share and (ii) pre-funded warrants to purchase an aggregate of 204,081 shares of Common Stock (the “Pre-Funded Warrants”), at a price to the public of $48.9999 per Pre-Funded Warrant, which represents the per share public offering price for the Common Stock less the $0.0001 per share exercise price for each such Pre-Funded Warrant.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312523168460/0001193125-23-168460-index.htm","confidence":1.0,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Morgan Stanley & Co. LLC, SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated, BMO Capital Markets Corp."},{"label":"Value","value":"$128.2 million net proceeds from public offering of common stock and pre-funded warrants"},{"label":"Effective","value":"2023-06-13"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}